200 related articles for article (PubMed ID: 16220109)
1. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
[TBL] [Abstract][Full Text] [Related]
2. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
Wiener D; Fang JL; Dossett N; Lazarus P
Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
[TBL] [Abstract][Full Text] [Related]
3. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
Chen G; Luo S; Kozlovich S; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
[TBL] [Abstract][Full Text] [Related]
4. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific Metabolism of the Tobacco-Specific Nitrosamine, NNAL.
Kozlovich S; Chen G; Lazarus P
Chem Res Toxicol; 2015 Nov; 28(11):2112-9. PubMed ID: 26452127
[TBL] [Abstract][Full Text] [Related]
6. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.
Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P
Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206
[TBL] [Abstract][Full Text] [Related]
7. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer.
Gallagher CJ; Muscat JE; Hicks AN; Zheng Y; Dyer AM; Chase GA; Richie J; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):823-8. PubMed ID: 17416778
[TBL] [Abstract][Full Text] [Related]
8. Prominent Stereoselectivity of NNAL Glucuronidation in Upper Aerodigestive Tract Tissues.
Kozlovich S; Chen G; Watson CJW; Lazarus P
Chem Res Toxicol; 2019 Aug; 32(8):1689-1698. PubMed ID: 31307193
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
[TBL] [Abstract][Full Text] [Related]
10. Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines.
Chen G; Dellinger RW; Gallagher CJ; Sun D; Lazarus P
Pharmacogenet Genomics; 2008 Mar; 18(3):181-91. PubMed ID: 18300939
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1.
Ren Q; Murphy SE; Dannenberg AJ; Park JY; Tephly TR; Lazarus P
Drug Metab Dispos; 1999 Sep; 27(9):1010-6. PubMed ID: 10460800
[TBL] [Abstract][Full Text] [Related]
12. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9.
Ren Q; Murphy SE; Zheng Z; Lazarus P
Drug Metab Dispos; 2000 Nov; 28(11):1352-60. PubMed ID: 11038164
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
14. UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.
Balliet RM; Chen G; Dellinger RW; Lazarus P
Drug Metab Dispos; 2010 Mar; 38(3):484-90. PubMed ID: 20007297
[TBL] [Abstract][Full Text] [Related]
15. Formation of NADP(H) analogs of tobacco-specific nitrosamines in rat liver and pancreatic microsomes.
Peterson LA; Ng DK; Stearns RA; Hecht SS
Chem Res Toxicol; 1994; 7(5):599-608. PubMed ID: 7841337
[TBL] [Abstract][Full Text] [Related]
16. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.
Chen G; Giambrone NE; Lazarus P
Pharmacogenet Genomics; 2012 Mar; 22(3):183-90. PubMed ID: 22228205
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
Staretz ME; Murphy SE; Patten CJ; Nunes MG; Koehl W; Amin S; Koenig LA; Guengerich FP; Hecht SS
Drug Metab Dispos; 1997 Feb; 25(2):154-62. PubMed ID: 9029045
[TBL] [Abstract][Full Text] [Related]
20. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
